Mixtures of xenoestrogens disrupt estradiol-induced non-genomic signaling and downstream functions in pituitary cells

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Viñas, René ^a   Watson, Cheryl S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; CASPASE 9; ESTROGEN; MITOGEN ACTIVATED PROTEIN KINASE; PROLACTIN; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG; XENOESTROGEN; 4,4' ISOPROPYLIDENEDIPHENOL; BENZHYDRYL DERIVATIVE; BIS(4-HYDROXYPHENYL)SULFONE; ESTRADIOL; NONYLPHENOL; PHENOL DERIVATIVE; POLLUTANT; SULFONE;

ALCOHOL; APOPTOSIS; BIOASSAY; CELL ORGANELLE; CONCENTRATION (COMPOSITION); ENZYME ACTIVITY; ESTROGENIC COMPOUND; FLUORESCENCE; FUNCTIONAL RESPONSE; GENOMICS; HORMONE; PHENOL; PHYSIOLOGICAL RESPONSE; POLLUTION EFFECT; SIGNALING; SURFACTANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; HYPOPHYSIS CELL; IMMUNOASSAY; NONHUMAN; PRIORITY JOURNAL; PROLACTIN RELEASE; PROTEIN PHOSPHORYLATION; RADIOIMMUNOASSAY; RAT; SIGNAL TRANSDUCTION; ANIMAL; CELL LINE; DRUG EFFECTS; HYPOPHYSIS; METABOLISM; PHOSPHORYLATION; POLLUTANT; TOXICITY;

ANIMALS; BENZHYDRYL COMPOUNDS; CELL LINE; CELL PROLIFERATION; ENVIRONMENTAL POLLUTANTS; ESTRADIOL; ESTROGENS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; JNK MITOGEN-ACTIVATED PROTEIN KINASES; PHENOLS; PHOSPHORYLATION; PITUITARY GLAND; RATS; SIGNAL TRANSDUCTION; SULFONES;

EID: 84877278530     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-26     Document Type: Article

References (64)

1. Reliable quantification of bisphenol A and its chlorinated derivatives in human breast milk using UPLC-MS/MS method. Cariot A, Dupuis A, Albouy-Llaty M, Legube B, Rabouan S, Migeot V, Talanta 2012 100 175 182 23141326
2. Environmental chemicals in pregnant women in the United States: NHANES 2003-2004. Woodruff TJ, Zota AR, Schwartz JM, Environ Health Perspect 2011 119 878 885 10.1289/ehp.1002727 21233055
3. Bisphenol A Global Industry Group, Bisphenol A: Information Sheet http://bisphenol-a.org/pdf/DiscoveryandUseOctober2002.pdf
4. Viable skin efficiently absorbs and metabolizes bisphenol A. Zalko D, Jacques C, Duplan H, Bruel S, Perdu E, Chemosphere 2011 82 424 430 10.1016/j.chemosphere.2010.09.058 21030062
5. Derivation of a bisphenol A oral reference dose (RfD) and drinking-water equivalent concentration. Willhite CC, Ball GL, McLellan CJ, J Toxicol Environ Health B Crit Rev 2008 11 69 146 10.1080/10937400701724303 18188738
6. Migration of bisphenol A from plastic baby bottles, baby bottle liners and reusable polycarbonate drinking bottles. Kubwabo C, Kosarac I, Stewart B, Gauthier BR, Lalonde K, Lalonde PJ, Food Addit Contam Part A Chem Anal Control Expo Risk Assess 2009 26 928 937 10.1080/02652030802706725 19680968
7. Exposure of the U.S. population to bisphenol A and 4-tertiary- octylphenol: 2003-2004. Calafat AM, Ye X, Wong LY, Reidy JA, Needham LL, Environ Health Perspect 2008 116 39 44 18197297
8. Bisphenol-A exposure during the period of blastocyst implantation alters uterine morphology and perturbs measures of estrogen and progesterone receptor expression in mice. Berger RG, Foster WG, De Catanzaro D, Reprod Toxicol 2010 30 393 400 10.1016/j.reprotox.2010.06.006 20599497
9. Neonatal exposure to bisphenol A alters reproductive parameters and gonadotropin releasing hormone signaling in female rats. Fernandez M, Bianchi M, Lux-Lantos V, Libertun C, Environ Health Perspect 2009 117 757 762 19479018
10. Estrogen receptor beta mediates rapid estrogen actions on gonadotropin-releasing hormone neurons in vivo. Abraham IM, Han SK, Todman MG, Korach KS, Herbison AE, J Neurosci 2003 23 5771 5777 12843281 (Pubitemid 36807856)
11. Neonatal exposure to bisphenol A and reproductive and endocrine alterations resembling the polycystic ovarian syndrome in adult rats. Fernandez M, Bourguignon N, Lux-Lantos V, Libertun C, Environ Health Perspect 2010 118 1217 1222 10.1289/ehp.0901257 20413367
12. Prenatal exposure to bisphenol A at environmentally relevant doses adversely affects the murine female reproductive tract later in life. Newbold RR, Jefferson WN, Padilla-Banks E, Environ Health Perspect 2009 117 879 885 19590677
13. Urine bisphenol-A (BPA) level in relation to semen quality. Li DK, Zhou Z, Miao M, He Y, Wang J, Ferber J, Herrinton LJ, Gao E, Yuan W, Fertil Steril 2011 95 625 630 10.1016/j.fertnstert.2010.09.026 21035116
14. Exposure to bisphenol A is associated with recurrent miscarriage. Sugiura-Ogasawara M, Ozaki Y, Sonta S, Makino T, Suzumori K, Hum Reprod 2005 20 2325 2329 10.1093/humrep/deh888 15947000 (Pubitemid 41418526)
15. Positive relationship between androgen and the endocrine disruptor, bisphenol A, in normal women and women with ovarian dysfunction. Takeuchi T, Tsutsumi O, Ikezuki Y, Takai Y, Taketani Y, Endocr J 2004 51 165 169 10.1507/endocrj.51.165 15118266 (Pubitemid 38657551)
16. In vivo effects of bisphenol A in laboratory rodent studies. Richter CA, Birnbaum LS, Farabollini F, Newbold RR, Rubin BS, Talsness CE, Vandenbergh JG, Walser-Kuntz DR, vom Saal FS, Reprod Toxicol 2007 24 199 224 10.1016/j.reprotox.2007.06.004 17683900 (Pubitemid 47385096)
17. NTP-CERHR expert panel report on the reproductive and developmental toxicity of bisphenol A. Chapin RE, Adams J, Boekelheide K, Gray LE Jr, Hayward SW, Lees PS, McIntyre BS, Portier KM, Schnorr TM, Selevan SG, Vandenbergh JG, Woskie SR, Birth Defects Res B Dev Reprod Toxicol 2008 83 157 395 10.1002/bdrb.20147 18613034 (Pubitemid 352002664)
18. Food and Drug Administration: Indirect Food Additives: Polymers. Docket No. FDA-2012-F-0031 http://www.gpo.gov/fdsys/pkg/FR-2012-07-17/pdf/2012-17366. pdf
19. Analysis of bisphenols in soft drinks by on-line solid phase extraction fast liquid chromatography-tandem mass spectrometry. Gallar-Ayala H, Moyano E, Galceran MT, Anal Chim Acta 2011 683 227 233 10.1016/j.aca.2010.10.034 21167975
20. Estrogenic activity of alkylphenols, bisphenol S, and their chlorinated derivatives using a GFP expression system. Kuruto-Niwa R, Nozawa R, Miyakoshi T, Shiozawa T, Terao Y, Environ Toxicol Pharmacol 2005 19 121 130 10.1016/j.etap.2004.05.009 21783468 (Pubitemid 39601909)
21. Comparison of two derivatization-based methods for solid-phase microextraction-gas chromatography-mass spectrometric determination of bisphenol A, bisphenol S and biphenol migrated from food cans. Vinas P, Campillo N, Martinez-Castillo N, Hernandez-Cordoba M, Anal Bioanal Chem 2010 397 115 125 10.1007/s00216-010-3464-7 20127078
22. Bisphenol s, a new bisphenol analogue, in paper products and currency bills and its association with bisphenol a residues. Liao C, Liu F, Kannan K, Environ Sci Technol 2012 46 6515 6522 10.1021/es300876n 22591511
23. Bisphenol s in urine from the United States and seven Asian countries: occurrence and human exposures. Liao C, Liu F, Alomirah H, Loi VD, Mohd MA, Moon HB, Nakata H, Kannan K, Environ Sci Technol 2012 46 6860 6866 10.1021/es301334j 22620267
24. Weak estrogenic transcriptional activities of Bisphenol A and Bisphenol S. Grignard E, Lapenna S, Bremer S, Toxicol In Vitro 2012 26 727 731 10.1016/j.tiv.2012.03.013 22507746
25. Estrogenic activity of dental materials and bisphenol-A related chemicals in vitro. Hashimoto Y, Nakamura M, Dent Mater J 2000 19 245 262 10.4012/dmj.19.245 11218845
26. Measurement of estrogenic activity of chemicals for the development of new dental polymers. Hashimoto Y, Moriguchi Y, Oshima H, Kawaguchi M, Miyazaki K, Nakamura M, Toxicol In Vitro 2001 15 421 425 10.1016/S0887-2333(01)00046-7 11566573 (Pubitemid 32889668)
27. Acute toxicity, mutagenicity, and estrogenicity of bisphenol-A and other bisphenols. Chen MY, Ike M, Fujita M, Environ Toxicol 2002 17 80 86 10.1002/tox.10035 11847978 (Pubitemid 34176768)
28. Bisphenol s disrupts estradiol-induced nongenomic signaling in a rat pituitary cell line: effects on cell functions. Vinas R, Watson CS, Environ Health Perspect 2013 121 3 352 358 10.1289/ehp.1205826 23458715
29. Nongenomic mechanisms of physiological estrogen-mediated dopamine efflux. Alyea RA, Watson CS, BMC Neurosci 2009 10 59 10.1186/1471-2202-10-59 19531209
30. Combinations of physiologic estrogens with xenoestrogens alter calcium and kinase responses, prolactin release, and membrane estrogen receptor trafficking in rat pituitary cells. Jeng YJ, Kochukov M, Watson CS, Environ Health 2010 9 61 10.1186/1476-069X-9-61 20950447
31. Combinations of physiologic estrogens with xenoestrogens alter ERK phosphorylation profiles in rat pituitary cells. Jeng YJ, Watson CS, Environ Health Perspect 2011 119 104 112 20870566
32. Xenoestrogens at picomolar to nanomolar concentrations trigger membrane estrogen receptor-alpha-mediated Ca2+ fluxes and prolactin release in GH3/B6 pituitary tumor cells. Wozniak AL, Bulayeva NN, Watson CS, Environ Health Perspect 2005 113 431 439 10.1289/ehp.7505 15811834 (Pubitemid 40601821)
33. Membrane estrogen receptors in GH3/B6 cells are associated with rapid estrogen-induced release of prolactin. Pappas TC, Gametchu B, Yannariello-Brown J, Collins TJ, Watson CS, Endocrine 1994 2 813 822 (Pubitemid 2135917)
34. Membrane estrogen receptor-enriched GH§ssub§3§esub§/ B6 cells have an enhanced non-genomic response to estrogen. Pappas TC, Gametchu B, Watson CS, Endocrine 1995 3 743 749 10.1007/BF03000207 21153164
35. Quantitative measurement of estrogen-induced ERK 1 and 2 activation via multiple membrane-initiated signaling pathways. Bulayeva NN, Gametchu B, Watson CS, Steroids 2004 69 181 192 10.1016/j.steroids.2003.12.003 15072920 (Pubitemid 38479391)
36. Xenoestrogen-induced ERK-1 and ERK-2 activation via multiple membrane-initiated signaling pathways. Bulayeva NN, Watson CS, Environ Health Perspect 2004 112 1481 1487 10.1289/ehp.7175 15531431 (Pubitemid 39517441)
37. Membrane estrogen receptor-alpha-mediated nongenomic actions of phytoestrogens in GH3/B6/F10 pituitary tumor cells. Jeng YJ, Kochukov MY, Watson CS, J Mol Signal 2009 4 2 10.1186/1750-2187-4-2 19400946
38. Alkylphenol xenoestrogens with varying carbon chain lengths differentially and potently activate signaling and functional responses in GH§ssub§3§esub§/B§ssub§6§esub§/F10 somatomammotropes. Kochukov MY, Jeng Y-J, Watson CS, Env Health Perspect 2009 117 723 730
39. Regulation of the membrane estrogen receptor-alpha: role of cell density, serum, cell passage number, and estradiol. Campbell CH, Bulayeva N, Brown DB, Gametchu B, Watson CS, FASEB J 2002 16 1917 1927 10.1096/fj.02-0182com 12468456 (Pubitemid 35462610)
40. Proliferative and anti-proliferative effects of dietary levels of phytoestrogens in rat pituitary GH3/B6/F10 cells-the involvement of rapidly activated kinases and caspases. Jeng YJ, Watson CS, BMC Cancer 2009 9 334 10.1186/1471-2407-9-334 19765307
41. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Vandenberg LN, Colborn T, Hayes TB, Heindel JJ, Jacobs DR Jr, Lee DH, Shioda T, Soto AM, Vom Saal FS, Welshons WV, Zoeller RT, Myers JP, Endocr Rev 2012 33 378 455 10.1210/er.2011-1050 22419778
42. Membrane effects of thyrotropin-releasing hormone and estrogen shown by intracellular recording from pituitary cells. Dufy B, Vincent J-D, Fleury H, Pasquier PD, Gourdji D, Vidal AT, Science 1979 204 509 511 10.1126/science. 107590 107590 (Pubitemid 9186278)
43. Membrane estrogen receptors identified by multiple antibody labeling and impeded-ligand binding. Pappas TC, Gametchu B, Watson CS, FASEB J 1995 9 404 410 7896011
44. Designing endocrine disruption out of the next generation of chemicals. Schug TT, Abagyan R, Blumberg B, Collins T, Crews D, DeFur P, Dickerson S, Edwards T, Gore A, Guillette LJ, Hayes T, Heindel J, Moores A, O' Brien KP, Patisaul HB, Al TT, Thayer K, Vandenberg L, Warner J, Watson C, Vom Saal FS, Zoeller RT, Myers JP, Green Chemistry 2013 15 181 198 http://pubs.rsc.org/en/ journals/journal/gc 10.1039/C2GC35055F
45. Subchronic exposure to phytoestrogens alone and in combination with diethylstilbestrol-pituitary tumor induction in Fischer 344 rats. Jeng YJ, Kochukov M, Nauduri D, Kaphalia BS, Watson CS, Nutr Metab (Lond) 2010 7 40 10.1186/1743-7075-7-40
46. Nonmonotonic dose-response relationships: mechanistic basis, kinetic modeling, and implications for risk assessment. Conolly RB, Lutz WK, Toxicol Sci 2004 77 151 157 14600281 (Pubitemid 38128655)
47. Nongenomic signaling pathways of estrogen toxicity. Watson CS, Jeng YJ, Kochukov MY, Toxicol Sci 2010 115 1 11 10.1093/toxsci/kfp288 19955490
48. Reproductive stimulation by low doses of xenoestrogens contrasts with the view of hormesis as an adaptive response. Weltje L, vom Saal FS, Oehlmann J, Hum Exp Toxicol 2005 24 431 437 10.1191/0960327105ht551oa 16235731 (Pubitemid 41433666)
49. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Hunter T, Cell 1995 80 225 236 10.1016/0092-8674(95)90405-0 7834742
50. Roles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistance. McCubrey JA, Steelman LS, Chappell WH, Abrams SL, Wong EW, Chang F, Lehmann B, Terrian DM, Milella M, Tafuri A, Stivala F, Libra M, Basecke J, Evangelisti C, Martelli AM, Franklin RA, Biochim Biophys Acta 2007 1773 1263 1284 10.1016/j.bbamcr.2006.10.001 17126425 (Pubitemid 47125967)
51. Inhibition of caspase-9 through phosphorylation at Thr 125 by ERK MAPK. Allan LA, Morrice N, Brady S, Magee G, Pathak S, Clarke PR, Nat Cell Biol 2003 5 647 654 10.1038/ncb1005 12792650 (Pubitemid 36818087)
52. Phosphorylation of caspase-9 by CDK1/cyclin B1 protects mitotic cells against apoptosis. Allan LA, Clarke PR, Mol Cell 2007 26 301 310 10.1016/j.molcel.2007.03.019 17466630 (Pubitemid 46617338)
53. Apoptosis and autophagy: regulation of caspase-9 by phosphorylation. Allan LA, Clarke PR, FEBS J 2009 276 6063 6073 10.1111/j.1742-4658.2009.07330.x 19788417
54. Phosphatase-mediated crosstalk between MAPK signaling pathways in the regulation of cell survival. Junttila MR, Li SP, Westermarck J, FASEB J 2008 22 954 965 18039929 (Pubitemid 351519953)
55. Opposing effects of ERK and p38-JNK MAP kinase pathways on formation of prions in GT1-1 cells. Nordstrom E, Fisone G, Kristensson K, FASEB J 2009 23 613 622 18824519
56. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME, Science 1995 270 1326 1331 10.1126/science.270.5240.1326 7481820
57. The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Meloche S, Pouyssegur J, Oncogene 2007 26 3227 3239 10.1038/sj.onc.1210414 17496918 (Pubitemid 46763017)
58. Signal transduction by the c-Jun N-terminal kinase (JNK)-from inflammation to development. Ip YT, Davis RJ, Curr Opin Cell Biol 1998 10 205 219 10.1016/S0955-0674(98)80143-9 9561845 (Pubitemid 28174763)
59. JNK signaling in apoptosis. Dhanasekaran DN, Reddy EP, Oncogene 2008 27 6245 6251 10.1038/onc.2008.301 18931691
60. Cisplatin induces a persistent activation of JNK that is related to cell death. Sanchez-Perez I, Murguia JR, Perona R, Oncogene 1998 16 533 540 10.1038/sj.onc.1201578 9484843 (Pubitemid 28062081)
61. Growth and cell cycle regulation of mRNA levels in GH3 cells. Rhode PR, Gorski J, Mol Cell Endocrinol 1991 82 11 22 10.1016/0303-7207(91)90004-C 1761163
62. Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA, Endocr Rev 1998 19 225 268 10.1210/er.19.3.225 9626554 (Pubitemid 29117815)
63. Food and Drug Administration, Drug Interaction Studies-Study Design, Data Analysis, Implications for Dosing, and Labeling Recommendations http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM292362.pdf
64. Mechanisms of membrane estrogen receptor-{alpha}-mediated rapid stimulation of Ca2+ levels and prolactin release in a pituitary cell line. Bulayeva NN, Wozniak A, Lash LL, Watson CS, Am J Physiol Endocrinol Metab 2005 288 388 E397 10.1152/ajpendo.00349.2004 15494610 (Pubitemid 40110648)